Status:
COMPLETED
Analysis of Risk Factors of Neurodevelopmental Disorder in Deaf Infants Under Ten Months of Age.
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Congenital Sensorineural Hearing Loss
Eligibility:
All Genders
Up to 10 years
Brief Summary
Among risk factors of neurodevelopmental disorder is congenital hearing loss. However, congenital deafness is neither necessary nor sufficient for the occurrence of warning signs of neurodevelopmental...
Detailed Description
Congenital deafness remains among well-known risk factors for Neurodevelopmental Disorders, in particular Autism Spectrum Disorders (ASD). According to current data of the literature, the risk of ASD ...
Eligibility Criteria
Inclusion
- Children with congenital deafness
- Follow-ups in the ENT department of the Necker hospital
- Having benefited from a pilot consultation, filmed, jointly carried out by a child psychiatrist from Therapeutic Childhood and Deafness Unit of St Maurice Hospitals (UTES) and a psychologist from the Necker ENT department for the assessment of neurodevelopmental risk
- Pilot consultation carried out before the child is 10 months old
- Information of the holders of parental authority and collection of their non-opposition to the study
Exclusion
- Children assessed after 10 months
- Opposition of legal representatives for the use of their child's medical data and of the film
Key Trial Info
Start Date :
August 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05423548
Start Date
August 3 2022
End Date
September 9 2022
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker-Enfants Malades
Paris, France, 75015